Evidence map›Paper›PMID 39529653›Full record

ArticleClinical and translational radiation oncology2025

Post-mastectomy hypofractionated versus conventionally fractionated radiation therapy for patients receiving immediate breast reconstruction: Subgroup analysis of a phase III randomized trial.

Xiaomeng Zhang, Xiaofang Wang, Yajuan Chu, Li Zhang, Jin Meng, Wei Shi, Xingxing Chen, Zhaozhi Yang, Xin Mei, Xiaoli Yu and 7 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical and translational radiation oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Xiaomeng ZhangDepartment of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
Xiaofang WangDepartment of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
Yajuan ChuDepartment of Radiation Oncology, Minhang Branch, Fudan University Shanghai Cancer Center, Shanghai 200240, China.
Li ZhangDepartment of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
Jin MengDepartment of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
Wei ShiDepartment of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
Xingxing ChenDepartment of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
Zhaozhi YangDepartment of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
Xin MeiDepartment of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
Xiaoli YuDepartment of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
Miao MoDepartment of Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
Zhen ZhangDepartment of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
Guangyu LiuDepartment of Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
Jiong WuDepartment of Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
Zhimin ShaoDepartment of Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
Xiaomao GuoDepartment of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
Jinli MaDepartment of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

•The incidence of complications is higher for patients with TE irradiated, then for those with PI, and the lowest for those with AT.•The use of hypofractionation in patients with any type of IBR does not seem to increase complications as compared to conventional fractionation.•Our findings might help to support further implementation of the hypofractionated schedule after IBR.

Identifiers

PMID39529653
PMCPMC11550153

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.